Johnson & Johnson Acquires Alios BioPharma for $1,750,000,000

  • Feed Type
  • Date
    10/1/2014
  • Company Name
    Alios BioPharma
  • Mailing Address
    260 East Grand Ave 2nd Floor South San Francisco, CA 94080 USA
  • Company Description
    Alios is discovering and developing novel therapeutic agents based on three platform technologies including: small molecule activators of innate immunity antiviral pathways (RNase L activation), phosphate protected nucleotide prodrug chemistry, and glycoprotein-engineering of interferons (Glycoferonâ).
  • Website
    http://www.aliosbiopharma.com
  • Transaction Type
    M&A
  • Transaction Amount
    $1,750,000,000
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    The acquisition will be paid for with all cash.

Trending on Xconomy